In myasthenia gravis (MG) patients, the frequency of MuSK-IgG and AChR-IgG Fab N-glycosylation sites is elevated in the circulatory system compared to healthy individuals, though this does not affect their binding capacity [38]. This evidence concerns the gene FANCB and myasthenia gravis.